SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001914879-24-000005
Filing Date
2024-09-03
Accepted
2024-09-03 16:33:41
Documents
3
Period of Report
2024-09-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1725395613.html 3  
1 FORM 3 wk-form3_1725395613.xml 3 1684
2 EX-24.POAFOX foxjennifer-poadocx.htm EX-24.POAFOX 4305
3 foxjennifer-poadocx001.jpg GRAPHIC 238318
  Complete submission text file 0001914879-24-000005.txt   335725
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address
Fox Jennifer Lynne (Reporting) CIK: 0001914879 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26642 | Film No.: 241274565